Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nature Materials|September 26, 2018
Large electrostrictive response in lead halide perovskitesBo Chen, Tao Li, Qingfeng Dong, et al.
Nature Materials|October 14, 2018
Publisher Correction: Large electrostrictive response in lead halide perovskitesBo Chen, Tao Li, Qingfeng Dong, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 9, 2021
Efficient and Stable Red Perovskite Light-Emitting Diodes with Operational Stability >300 hHanming Li, Hong Lin, Dan Ouyang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 22, 2024
Optimizing Energy Levels and Improving Film Compactness in PbS Quantum Dot Solar Cells by Silver DopingJing Li, Xiaoyu Zhang, Zeke Liu, et al.
Light, Science & Applications|April 3, 2023
Detector-grade perovskite single-crystal wafers via stress-free gel-confined solution growth targeting high-resolution ionizing radiation detectionYilong Song, Lixiang Wang, Yongqiang Shi, et al.
Angewandte Chemie (International Ed. in English)|March 31, 2025
Pressure-Induced Emission Luminogens Enable Optical Logic Gates Toward Lighting, Scintillators, and Anti-CounterfeitingWenya Zhao, Guanjun Xiao, Shi Qiu, et al.
Arthritis Research & Therapy|September 7, 2024
A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)Xiaomei Leng, Piotr Leszczyński, Slawomir Jeka, et al.
The Lancet. Rheumatology|January 23, 2024
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trialXiaomei Leng, Piotr Leszczyński, Sławomir Jeka, et al.
Cancer Medicine|November 7, 2023
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III studyLikun Chen, Jose David Gomez Rangel, Timucin Cil, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 9, 2025
Diverse Perovskite Solar Cells: Progress, Challenges, and PerspectivesLixiu Zhang, Mei Zhang, Hantao Wang, et al.
Pageof 8